Patients with the metabolic syndrome (MetS) have impaired insulin-induced enhancement of vasodilator responses. The incretin hormone glucagon-like peptide 1 (GLP-1), beyond its effects on blood glucose, has beneficial actions on vascular function. This study, therefore, aimed to assess whether GLP-1 affects insulin-stimulated vasodilator reactivity in patients with the MetS.
Tesauro, M., Schinzari, F., Adamo, A., Rovella, V., Martini, F., Mores, N., et al. (2013). Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. DIABETES CARE, 36(3), 683-689 [10.2337/dc12-0763].
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome
TESAURO, MANFREDI;Rovella, V;LAURO, DAVIDE;
2013-03-01
Abstract
Patients with the metabolic syndrome (MetS) have impaired insulin-induced enhancement of vasodilator responses. The incretin hormone glucagon-like peptide 1 (GLP-1), beyond its effects on blood glucose, has beneficial actions on vascular function. This study, therefore, aimed to assess whether GLP-1 affects insulin-stimulated vasodilator reactivity in patients with the MetS.| File | Dimensione | Formato | |
|---|---|---|---|
|
GLP-1 tesauro.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
788.04 kB
Formato
Adobe PDF
|
788.04 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
